Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
Objective. Clopidogrel is widely used for preventing ischemic complications related to cardiovascular diseases. However, many patients experience clopidogrel resistance (CR). The polymorphisms of CYP2C19 have been implicated in CR, but CYP2C19 polymorphism considerably varies with both ethnic group...
Saved in:
Main Authors: | Rong Chang, Wenqin Zhou, Yi Ye, Xiaofei Zhang, Yanmin Liu, Jinchun Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Genetics Research |
Online Access: | http://dx.doi.org/10.1155/2022/1901256 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome
by: Wenxing Peng, et al.
Published: (2019-01-01) -
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Maurizio Paciaroni, et al.
Published: (2019-01-01) -
Inflammation and endothelial gene polymorphism are associated with ischemic stroke
by: Wanli Chen, et al.
Published: (2025-02-01) -
The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
by: Yanti Nasyuhana Sani, et al.
Published: (2013-01-01) -
Interleukin-16 Polymorphism Is Associated with an Increased Risk of Ischemic Stroke
by: Xiao-li Liu, et al.
Published: (2013-01-01)